• Mon espace de travail
  • Aide IRIS
  • Par Publication Par Personne Par Unité
    • English
    • Français
  • Se connecter
Logo du site

IRIS | Système d’Information de la Recherche Institutionnelle

  • Accueil
  • Personnes
  • Publications
  • Unités
  • Périodiques
UNIL
  • English
  • Français
Se connecter
IRIS
  • Accueil
  • Personnes
  • Publications
  • Unités
  • Périodiques
  • Mon espace de travail
  • Aide IRIS

Parcourir IRIS

  • Par Publication
  • Par Personne
  • Par Unité
  1. Accueil
  2. IRIS
  3. Publication
  4. Roles and challenges of a Swiss hospital pharmacy during the COVID-19 pandemic
 
  • Détails
Titre

Roles and challenges of a Swiss hospital pharmacy during the COVID-19 pandemic

Type
abstract de conférence/colloque
Institution
Externe
Auteur(s)
Schumacher, L.
Auteure/Auteur
Blatrie, C.
Auteure/Auteur
Krähenbühl, S.
Auteure/Auteur
Pasteur, C.
Auteure/Auteur
Blanc, A.-L.
Auteure/Auteur
Pellaton, C.
Auteure/Auteur
Rouiller, F.
Auteure/Auteur
Widmer, N.
Auteure/Auteur
Liens vers les personnes
Widmer, Nicolas  
Titre du livre ou conférence/colloque
Pharmacy Education
Unité
International Pharmaceutical Federation (FIP) Virtual 2020
Adresse
September 4-25, 2020
Statut éditorial
Publié
Date de publication
2020
Volume
20
Numéro
3
Première page
41
Peer-reviewed
Oui
Langue
anglais
Résumé
Background: On March 16, 2020, because of the COVID-19 pandemic, the Swiss Federal Council declared an ‘extraordinary situation’ in terms of the Epidemics Act.
Purpose: To assess the roles of an inter-hospital pharmacy in the fight against SARS-CoV-2.
Method: All missions performed by our pharmacy were systematically collected and evaluated. They were also compared to its official duties.
Results: Specific missions, which have been mainly managed by the crisis unit and the four departments of the pharmacy (Pharmaceutical Logistics, Drug Manufacturing, Clinical Pharmacy and Nursing Homes Supply), were: 1) human resources continuity; 2) specific drug supply (for both hospitals and nursing homes; e.g. anaesthetics, sedatives, antiviral drugs, incl. for clinical trials); 3) clinical assistance (especially in the ICU of the main acute hospital); 4) individual drug manufacturing (e.g. hydroxychloroquine oral solution); 5) on-site pharmacies management; 6) own infrastructure securing (especially in term of hygiene); 7) hand disinfectant production; and 8) hygienic masks supply for healthcare professionals in the area. The two last missions were out of the traditional duties of our pharmacy and have been achieved with the support of staff from the Swiss civil protection. A particular challenge was the management of the shortage of various products and the identification of alternative therapeutic options.
Conclusion: Our pharmacy has faced various challenges during the acute pandemic situation. Some missions performed were even beyond our traditional ones. The disaster plan of our pharmacy has to be further developed, as well as the associated training of the staff, based on the lessons learned from this pandemic.
PID Serval
serval:BIB_D1B329727EF1
DOI
10.46542/pe.2020.203.4065
Permalien
https://iris.unil.ch/handle/iris/181368
URL éditeur
https://pharmacyeducation.fip.org/pharmacyeducation/article/view/1159
Date de création
2020-11-12T17:24:51.095Z
Date de création dans IRIS
2025-05-21T01:00:31Z
Fichier(s)
En cours de chargement...
Vignette d'image
Nom

FIP20_phel_covid.pdf

Version du manuscrit

published

Taille

7.27 MB

Format

Adobe PDF

PID Serval

serval:BIB_D1B329727EF1.P001

Somme de contrôle

(MD5):463ca210f10297d441c160a76c6de7ef

  • Copyright © 2024 UNIL
  • Informations légales